{
  "pmcid": "11562753",
  "sha256": "ce817b7be170bab969a961ec2005454d3a45e09fd327451f761101953bfb8ae9",
  "timestamp_utc": "2025-11-09T23:17:35.778583+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.760859931416519,
    "reading_ease": 19.76812186758113,
    "word_count": 223
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Noninvasive Focused Ultrasound for Chronic Pain"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "double-blind, randomised, sham-controlled crossover trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "included participants aged 18-65 with chronic pain. Conducted at the University of Utah"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either active or sham ultrasound stimulation"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates a noninvasive focused ultrasound method targeting the anterior cingulate cortex (ACC) for pain relief"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pain intensity reduction, assessed using the Brief Pain Inventory over 7 days"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was maintained for participants and outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Twenty-three participants were randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "20 completing the study"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Active stimulation led to a 60% reduction in pain immediately post-intervention, 43% on day 1, and 33% on day 7. Sham stimulation resulted in reductions of 14.4%, 12.3%, and 6.6%, respectively. The effect size was significant (p < 0.05)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No serious adverse events were reported; mild side effects resolved within 24 hours"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov NCT05674903"
      },
      "Funding": {
        "score": 1,
        "evidence": "Supported by the University of Utah"
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}